Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Aspirin · Bayer Extra Strength Aspirin For Migraine Pain, Vazalore

Small molecule · Inhibitor of Cyclooxygenase (prostaglandin-endoperoxide synthase) (PTGS1) and Cyclooxygenase-2 (PTGS2) · developed by Bayer

Approved FDA, Oct 2001
3 Registered trials

What is Aspirin?

Aspirin is an orally given non-steroidal anti-inflammatory small molecule that acetylates serine residues in cyclooxygenase enzymes, reducing prostaglandin synthesis and platelet aggregation. It is studied in prostate cancer, germ cell and testicular cancers, chronic myeloid leukemia, and venous thromboembolism.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Bayer Extra Strength Aspirin For Migraine Pain, Vazalore, BAY1019036, NSC-27223, NSC-406186, Acetylsalicylic Acid (ASA)
Drug type
Small molecule
Targets
Cyclooxygenase (prostaglandin-endoperoxide synthase) (PTGS1), Cyclooxygenase-2 (PTGS2)
Mechanism
Inhibitor of Cyclooxygenase (prostaglandin-endoperoxide synthase) (PTGS1) and Cyclooxygenase-2 (PTGS2)
Pathways
prostaglandin synthesis, platelet aggregation, inflammation
Therapy area
Cardiovascular, Oncology
Developer
Bayer
In trials of
AIM, CDIO, INCY, REGN, RNA
FDA status
Approved as Bayer Extra Strength Aspirin For Migraine Pain, Vazalore (October 18, 2001), NDA021317
UNII
R16CO5Y76E

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07213778 Phase 3 Symptomatic Venous Thromboembolism (VTE) Recruiting REGN
NCT06866964 Phase 2 Germ Cell Tumor Recruiting RNA
NCT03899987 Phase 2 Prostate Adenocarcinoma Active not recruiting AIM

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Germ Cell TumorProstate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8Symptomatic Venous Thromboembolism (VTE)Testicular CancerChronic Myeloid Leukemia, Chronic Phase

Other drugs acting on PTGS1 / PTGS2

Sources

Updated Nov 8, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.